StockWatch
·

Piramal Pharma Ltd Q1 FY26 Results

PPLPHARMAQ1 FY26 Results
Filing
MetricValue ( Cr)vs Q4 FY25
Revenue1.9K29.8%
Total Income2.0K28.8%
Expenditure2.1K16.9%
PBT-97.59138.0%
Net Profit-81.70153.2%
OPM6.59%13.78pp
NPM-4.10%9.59pp
EPS0.6246.5%
View full financials

Informational and educational content only. Not investment advice.